Travel Vaccines

With measles cases on the rise globally and with an outbreak of measles in communities right here in the United States, adults should ensure they are adequately vaccinated against this serious and potentially fatal disease.

The single-dose oral travel vaccine for cholera should be administered 10 days before visiting an affected area.

US citizens are increasingly traveling to international destinations, with Americans making 38 million visits abroad in 2017. Fortunately, pharmacists are well-placed to assist patients in their travel health needs.

This is the only vaccination approved in the United States to prevent this bacterial disease.

Cruises can be a fun and exciting way to vacation during the holidays.

This virus is found in tropical and subtropical areas in South America and Africa.

Summer is a popular time to travel, but it is especially important to remind patients about measles outbreaks and prevention strategies.

Traveling abroad can expose patients to a number of risks—infectious diseases, foodborne illness, and transportation accidents.

Vaxchora is the first approved vaccine for protection against cholera.

To help patients prepare for a safe and healthy travel season this summer and beyond, MinuteClinic has added several new travel-related services and immunizations.

US adults traveling to cholera-affected areas can now be vaccinated against the disease.

The FDA has approved Vaxchora, a vaccine that can prevent cholera caused by serogroup 01 in adults aged 18 to 64 years who are traveling to cholera-affected areas.

Pharmacists interested in providing more services to patients traveling domestically or abroad can tap into a big business opportunity.

Pharmacists can serve as an important resource for patients traveling abroad.

Learn what the latest guidelines from the American Academy of Pediatrics recommend for meningococcal vaccination among children, adolescents, and young adults.

Travel medicine service is an opportunity community pharmacies should consider integrating into the patient-care model.